TTR and Alzheimer disease: Studies aimed at finding TTR ligands acting as amyloidogenesis inhibitors for therapeutic intervention in TTR-associated amyloidotic polyneuropathies or acting as molecular chaperones to enhance the TTR:Aβ interaction and improve the neuroprotective effect in AD do require large amounts of hTTR protein to conduct in vitro screening assays.